Eikon Therapeutics, Inc. Common Stock (NASDAQ: EIKN) is a Healthcare company (Biotechnology) with a market capitalization of $279M. The Maz Rating grades it against the other companies in its sector.
Eikon Therapeutics, Inc. Common Stock's current Maz Rating and its five factor grades are for members: log in to see them.
At $5.15, Eikon Therapeutics, Inc. Common Stock trades at 0.7x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -258.1%, return on invested capital of -54.6% and a free cash flow yield of -96.0%. On the balance sheet: a debt-to-equity ratio of 0.65 and a current ratio of 7.21. Over the past 52 weeks the share price ranged from $4.95 to $17.40, with a beta of 0.94.
Eikon Therapeutics, Inc. Common Stock does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Sell, for a Sell consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.